397 related articles for article (PubMed ID: 12031278)
1. Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington's disease.
Alberch J; Pérez-Navarro E; Canals JM
Brain Res Bull; 2002 Apr; 57(6):817-22. PubMed ID: 12031278
[TBL] [Abstract][Full Text] [Related]
2. Neurturin protects striatal projection neurons but not interneurons in a rat model of Huntington's disease.
Pérez-Navarro E; Akerud P; Marco S; Canals JM; Tolosa E; Arenas E; Alberch J
Neuroscience; 2000; 98(1):89-96. PubMed ID: 10858615
[TBL] [Abstract][Full Text] [Related]
3. Intrastriatal grafting of a GDNF-producing cell line protects striatonigral neurons from quinolinic acid excitotoxicity in vivo.
Pérez-Navarro E; Arenas E; Marco S; Alberch J
Eur J Neurosci; 1999 Jan; 11(1):241-9. PubMed ID: 9987028
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.
Emerich DF; Winn SR; Hantraye PM; Peschanski M; Chen EY; Chu Y; McDermott P; Baetge EE; Kordower JH
Nature; 1997 Mar; 386(6623):395-9. PubMed ID: 9121555
[TBL] [Abstract][Full Text] [Related]
5. Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease.
Araujo DM; Hilt DC
Neuroscience; 1997 Dec; 81(4):1099-110. PubMed ID: 9330371
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members.
Gratacòs E; Pérez-Navarro E; Tolosa E; Arenas E; Alberch J
J Neurochem; 2001 Sep; 78(6):1287-96. PubMed ID: 11579137
[TBL] [Abstract][Full Text] [Related]
7. Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease.
Pérez-Navarro E; Canudas AM; Akerund P; Alberch J; Arenas E
J Neurochem; 2000 Nov; 75(5):2190-9. PubMed ID: 11183872
[TBL] [Abstract][Full Text] [Related]
8. Neurotrophic factors in Huntington's disease.
Alberch J; Pérez-Navarro E; Canals JM
Prog Brain Res; 2004; 146():195-229. PubMed ID: 14699966
[TBL] [Abstract][Full Text] [Related]
9. Striatopallidal neurons are selectively protected by neurturin in an excitotoxic model of Huntington's disease.
Marco S; Pérez-Navarro E; Tolosa E; Arenas E; Alberch J
J Neurobiol; 2002 Mar; 50(4):323-32. PubMed ID: 11891666
[TBL] [Abstract][Full Text] [Related]
10. AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease.
Kells AP; Fong DM; Dragunow M; During MJ; Young D; Connor B
Mol Ther; 2004 May; 9(5):682-8. PubMed ID: 15120329
[TBL] [Abstract][Full Text] [Related]
11. Excitatory amino acids differentially regulate the expression of GDNF, neurturin, and their receptors in the adult rat striatum.
Marco S; Canudas AM; Canals JM; Gavaldà N; Pérez-Navarro E; Alberch J
Exp Neurol; 2002 Apr; 174(2):243-52. PubMed ID: 11922665
[TBL] [Abstract][Full Text] [Related]
12. Brain-derived neurotrophic factor, neurotrophin-3 and neurotrophin-4/5 differentially regulate the phenotype and prevent degenerative changes in striatal projection neurons after excitotoxicity in vivo.
Pérez-Navarro E; Alberch J; Neveu I; Arenas E
Neuroscience; 1999; 91(4):1257-64. PubMed ID: 10391433
[TBL] [Abstract][Full Text] [Related]
13. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease.
Hughes PE; Alexi T; Williams CE; Clark RG; Gluckman PD
Neuroscience; 1999; 92(1):197-209. PubMed ID: 10392842
[TBL] [Abstract][Full Text] [Related]
14. Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease.
McBride JL; Ramaswamy S; Gasmi M; Bartus RT; Herzog CD; Brandon EP; Zhou L; Pitzer MR; Berry-Kravis EM; Kordower JH
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9345-50. PubMed ID: 16751280
[TBL] [Abstract][Full Text] [Related]
15. Glial cell line-derived neurotrophic factor protects striatal calbindin-immunoreactive neurons from excitotoxic damage.
Pérez-Navarro E; Arenas E; Reiriz J; Calvo N; Alberch J
Neuroscience; 1996 Nov; 75(2):345-52. PubMed ID: 8931001
[TBL] [Abstract][Full Text] [Related]
16. Adenoviral vector-mediated delivery of glial cell line-derived neurotrophic factor provides neuroprotection in the aged parkinsonian rat.
Connor B
Clin Exp Pharmacol Physiol; 2001 Nov; 28(11):896-900. PubMed ID: 11703392
[TBL] [Abstract][Full Text] [Related]
17. Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease.
Canals JM; Pineda JR; Torres-Peraza JF; Bosch M; Martín-Ibañez R; Muñoz MT; Mengod G; Ernfors P; Alberch J
J Neurosci; 2004 Sep; 24(35):7727-39. PubMed ID: 15342740
[TBL] [Abstract][Full Text] [Related]
18. Glial cell line-derived neurotrophic factor attenuates the locomotor hypofunction and striatonigral neurochemical deficits induced by chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid.
Araujo DM; Hilt DC
Neuroscience; 1998 Jan; 82(1):117-27. PubMed ID: 9483508
[TBL] [Abstract][Full Text] [Related]
19. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease.
Glass M; Dragunow M; Faull RL
Neuroscience; 2000; 97(3):505-19. PubMed ID: 10828533
[TBL] [Abstract][Full Text] [Related]
20. Disease Modification Through Trophic Factor Delivery.
Savolainen M; Emerich D; Kordower JH
Methods Mol Biol; 2018; 1780():525-547. PubMed ID: 29856034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]